Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells

Clinical Cancer Research

Volumn 4, Issue 7, 1998, Pages 1711-1717

  Lee, Yoonik ^a   Park, Ui Sun ^a   Choi, Inpyo ^a   Yoon, Seung Kew ^b   Park, Young Min ^b   Lee, Young Ik ^a,c  

^a Korea Institute of Science and Technology   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; VIRUS PROTEIN;

ARTICLE; BLOOD LEVEL; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE DELETION; GENE INDUCTION; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; INFLAMMATION; LIVER CANCER; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

BINDING SITES; CARCINOMA, HEPATOCELLULAR; GENETIC VECTORS; HEPATITIS, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; INTERLEUKIN-6; LIVER CIRRHOSIS; LIVER NEOPLASMS; NF-KAPPA B; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031746396     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Castell, J. V., Gomez-Lechon, M. J., David, M., Hirano, T., Kishimoto, T., and Heinrich, P. C. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett., 232: 347-350, 1988.
2. Akira, S., and Kishimoto, T. IL-6 and NF-IL-6 in acute-phase response and viral infection. Immunol. Rev., 127: 25-50, 1992.
3. Sehgal, P. B. Regulation of IL-6 gene expression. Immunol. Res., 143: 724-734, 1992.
4. Hirano, T., Matsuda, T., Turner, M., Miyaska, N., and Kishimoto, T. Excessive production of interleukin 6/B cell-stimulating factor-2 in rheumatoid arthritis. Eur. J. Immunol., 18: 1797-1801, 1988.
5. Kishimoto, T., and Hirano, T. Molecular response of B lymphocyte response. Annu. Rev. Immunol., 6: 485-512, 1988.
6. Diviere, J., Content, J., and Denys, C. High interleukin-6 serum levels and increased production by leukocytes in alcoholic liver cirrhosis: correlation with IgA serum levels and lymphokine production. Clin. Exp. Immunol., 77: 221-225, 1989.
7. Karumus, S., and Shinagawa, T. Interleukin-6 production by peripheral blood mononuclear cells in patient chronic hepatitis B virus infection and primary biliary cirrhosis. Gastroenterology, 28: 18-24. 1993.
8. Karumus, S., Shinagawa, T., and Ishikawa, T. Serum interleukin-6 levels in patients with chronic hepatitis B. Am. J. Gastroenterol., 86: 1804-1808, 1991.
9. Sen, Y., Tokushige, K., and Isono, E. Elevated serum interleukin-6 levels in patients with acute hepatitis. J. Clin. Immunol., 12: 192-200, 1992.
10. Twu, J. S., and Robinson, W. S. Hepatitis B virus X gene can transactivate heterologous viral sequences. Proc. Natl. Acad. Sci. USA, 86: 2046-2050, 1989.
11. Feitelson, M. Hepatitis B virus infection and primary hepatocellular carcinoma. Clin. Microbiol. Rev., 5: 275-301, 1992.
12. Sun, Y., Tokushige, K., Isono, E., Yamauchi, K, and Obata, H. Elevated serum IL-6 levels in patients with acute hepatitis. J. Clin. Immunol., 12: 197-200, 1992.
13. Nakalayashi, H., Taketa, T., and Miyano, K. Growth of human hepatoma cell lines with differentiated function in chemically defined medium. Cancer Res., 42: 3858-3863, 1982.
14. Knowles, B. B., Howe, C. C., and Aden, D. P. Human hepatocellular carcinoma cell lines secret the major plasma proteins and hepatisis B surface antigen. Science (Washington DC), 209: 497-499, 1980.
15. Graham, F. L., and Van der Eb, A. J. A new technique for the assay of infectivity of human adenovirus DNA. Virology, 52: 456-457, 1973.
16. German, C. M., Moffat, L. F., and Howard, B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol., 2: 1044-1051, 1982.
17. Kim, Y. S., and Kang, H. S. Complete nucleotide sequence of Korean type hepatitis B virus. Korean Biochem. J., 17: 7076-7081, 1984.
18. Kim, Y. H., Kang, S. K., and Lee, Y. I. Functional analysis of hepatitis B virus transactivator-X: implication of the leucine zipper like region and C-terminal seven conserved amino acid functional region. Biochem. Biophys. Res. Commun., 197: 894-903, 1993.
19. 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists. Proc. Natl. Acad. Sci. USA, 85: 6701-6705, 1988.
20. Hyun, S. W., Kim, S. J., Park, K. C., Rho, H. M., and Lee, Y. I. Charaterization of the P4 promoter region of the human insulin like growth factor II gene. FEBS Lett., 332: 153-158, 1993.
21. Smith, J. D., Melian, A., Leff, T., and Breslow, J. L. Expression of the human apoprotein E gene is regulated by multiple positive and negative elements. J. Biol. Chem., 263: 8300-8308, 1988.
22. Sen, R., and Baltimore, D. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell, 47: 921-928, 1986.
23. Sehgal, P. B., Grieninger, G., and Tosato, G. Regulation of the acute phase and immune reponses: interleukin-6. Ann. N. Y. Acad. Sci., 557: 1-583, 1989.
24. Sehgal, P. B. Interleukin-6: a regulator of plasma protein gene expression in hepatic and non-hepatic tissues. Mol. Biol. Med., 7: 117-130, 1990.
25. 2/ IL-6 in serum and body fluids during acute bacterial infection. J. Immunol., 142: 948-953, 1989.
26. Ray, A., Laforge, K. S., and Sehgal, P. B. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion. Mol. Cell. Biol., 10: 5736-5746, 1990.
27. Ray A., Sassone-Corsi, P., and Sehgal, P. B. A multipul cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similaritities with c-fos gene regulation. Mol. Cell. Biol., 9: 5537-5547, 1989.
28. Isshiki, H., Akira, S., Tanabe, O., Nakajima, T., Shimamtoto, T., Hirano, T., and Kishimoto, T. Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene. Mol. Cell. Biol., 10: 2757-2764, 1990.
29. Santhanam, U., Ray, A., and Sehgal, P. B. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA. 88: 7605-7609. 1991.
30. Libermann, T. A., and Baltimore, D. Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol. Cell. Biol. 10: 2327-2334, 1990.
31. Kakumu, S., Shinagawa, T., Ishikawa, T., Yoshioka, K., Wskita, T., Ito, Y., Takaynagi, M., and Ida, N. Serum IL-6 levels in patients with chronic hepatitis B. Am. J. Gastroenterol., 86: 1804-1808, 1991.
32. Anastassakos, A. C., Alexander, G. M., Wolstencroft, R. A. Portman, B., Panayi, G., Dumode, D. C., Eddleston, A. L. W. F., and Williams, R. Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology, 94: 999-1005, 1998.
33. Choi, I., Kang, H., Yang, Y., and Pyun, K. IL-6 induces hepatic inflammation and collagen synthesis in vivo. Clin. Exp. Immunol., 95: 530-535, 1994.
34. Muto, Y., Noun-Aria, K. T., Meager, A., Alexander, G. J. M., Eddleston, A. L., and William, R. Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet, 9: 72-74, 1988.
35. Kim, C. M., Koike, K., Saito, T., Miyamura, T. and Gilbert, J. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (Lond.), 351: 317-320, 1991.